Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Processa Pharmaceuticals (PCSA) Q2 2024 Earnings
PCSA
10
May
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-1.18
-0.81
-0.45
-0.08
Details
Expected EPS
-1.18
Actual EPS
-1.11
Surprise EPS
0.07
Surprise Percent
+5.93%
Description
Processa Pharmaceuticals (PCSA) has reported earnings of -1.11 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login